Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region

Biochemical Journal

Volumn 411, Issue 3, 2008, Pages 515-522

  Fujisawa, Daisuke ^a   Yamazaki, Yasuo ^a   Lomonte, Bruno ^b   Morita, Takashi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Kinase insert domain containing receptor (KDR); Phospholipase A2; Snake venom; Synthetic peptide; Vascular endothelial growth factor (VEGF)

Indexed keywords

BINDING ENERGY; CATALYST ACTIVITY; GROWTH KINETICS; PEPTIDES;

KINASE INSERT DOMAIN-CONTAINING RECEPTOR (KDR); PHOSPHOLIPASE; SNAKE VENOM; SYNTHETIC PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ENZYMES;

PHOSPHOLIPASE A2; SNAKE VENOM; STROMELYSIN; VASCULOTROPIN RECEPTOR 2; PEPTIDE;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL GROWTH; ENDOTHELIUM CELL; ENZYME BINDING; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; THROMBOCYTE AGGREGATION; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ELECTRICITY; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SURFACE PLASMON RESONANCE; SYNTHESIS;

AGKISTRODON PISCIVORUS PISCIVORUS; SERPENTES; VIPERIDAE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATALYSIS; CONSERVED SEQUENCE; ELECTROSTATICS; ENZYME ACTIVATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOLIPASES A2; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SNAKE VENOMS; SURFACE PLASMON RESONANCE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 42449097135     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20080078     Document Type: Article

References (31)

1. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endow. Rev. 25, 581-611
2. Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371
3. Yamazaki, Y. and Morita, T. (2006) Molecular and functional diversity of vascular endothelial growth factors. Mol. Diversity 10, 515-527
4. Ogawa, S., Oku, A., Sawano, A., Yamaguchi, S., Yazaki, Y. and Shibuya, M. (1998) A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273, 31273-31282
5. Meyer, M., Clauss, M., Lepple-Wienhues, A., Waltenberger, J., Augustin, H. G., Ziehe, M., Lanz, C., Buttner, M., Rziha, H. J. and Dehio, C. (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18, 363-374
6. Wise, L. M., Veikkola, T., Mercer, A. A., Savory, L. J., Fleming, S. B., Caesar, C., Vitali, A., Makinen, T., Alitalo, K. and Stacker, S. A. (1999) Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc. Natl. Acad. Sci. U.S.A. 96, 3071-3076
7. Yamazaki, Y., Takani, K., Atoda, H. and Morita, T. (2003) Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J. Biol. Chem. 278, 51985-51988
8. Takahashi, H., Hattori, S., Iwamatsu, A., Takizawa, H. and Shibuya, M. (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J. Biol. Chem. 279, 46304-46314
9. Yamazaki, Y., Nakano, Y., Imamura, T. and Morita, T. (2007) Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem. Biophys. Res. Commun. 355, 693-699
10. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488, 1-19
11. 2 enzymes. Toxicon 42, 827-840
12. 2 isozyme genes. Proc. Natl. Acad. Sci. U.S.A. 92, 5605-5609
13. 2 from snake venom. Toxicon 42, 841-854
14. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42, 885-901
15. 2 homologue from Vipera ammodytes venom. Eur. J. Biochem. 202, 1165-1168
16. 2 myotoxin. Toxicon 47, 797-811
17. 2 isozymes in the southwestern islands of Japan and Taiwan. Toxicon 48, 672-682
18. 2. Biochim. Biophys. Acta 1760, 462-171
19. 2: insight from the anion-assisted dimer. Arch. Biochem. Biophys. 433, 96-106
20. 2. J. Biol. Chem. 280, 29989-29992
21. Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A. and Anand-Apte, B. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9, 407-415
22. Ng, E. W., Shima, D. T., Calias, P., Cunningham, Jr, E. T., Guyer, D. R. and Adamis, A. P. (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5, 123-132
23. Soker, S., Gollamudi-Payne, S., Fidder, H., Charmahelli, H. and Klagsbrun, M. (1997) Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. Biol. Chem. 272, 31582-31588
24. Jia, H., Jezequel, S., Lohr, M., Shaikh, S., Davis, D., Soker, S., Selwood, D. and Zachary, I. (2001) Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF. Biochem. Biophys. Res. Commun. 283, 164-173
25. Zilberberg, L., Shinkaruk, S., Lequin, O., Rousseau, B., Hagedorn, M., Costa, F., Caronzolo, D., Balke, M., Canron, X., Convert, O. et al. (2003) Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J. Biol. Chem. 278, 35564-35573
26. Yamazaki, Y., Tokunaga, Y., Takani, K. and Morita, T. (2005) Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. Biochemistry 44, 8858-8864
27. Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Plouet, J., Derbin, C., Perret, G. and Mazie, J. C. (2000) Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 19, 1525-1533
28. Hetian, L., Ping, A., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., Lin, M., Meisheng, L., Junshan, Y. and Chengchao, S. (2002) A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J. Biol. Chem. 277, 43137-43142
29. El-Mousawi, M., Tchistiakova, L., Yurchenko, L., Pietrzynski, G., Moreno, M., Stanimirovic, D., Ahmad, D. and Alakhov, V. (2003) A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library. J. Biol. Chem. 278, 46681-46691
30. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260, 11627-11634
31. 2. Biochem. Int. 28, 895-903